Economist John E. Calfee (1941-2011) studied the pharmaceutical industry and the Food and Drug Administration (FDA), along with the economics of tobacco, tort liability, and patents. He previously worked at the Federal Trade Commission's Bureau of Economics. He had also taught marketing and consumer behavior at the business schools of the University of Maryland at College Park and Boston University. While Mr. Calfee's writings are mostly on pharmaceutical markets and FDA regulation, his academic articles and opinion pieces covered a variety of topics, from patent law and tort liability to advertising and consumer information. His books include Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Biotechnology and the Patent System (AEI Press, 2007). Mr. Calfee wrote regularly for AEI's Health Policy Outlook series. He testified before Congress and federal agencies on various topics, including alcohol advertising; biodefense vaccine research; international drug prices; and FDA oversight of drug safety.
With no end to the obesity epidemic in sight, several states and cities have proposed soda taxes on sugar-sweetened soda and other beverages. At this conference, experts John E. Calfee of AEI and Jamie Chriqui of the University of Illinois at Chicago will analyze the evidence on soda taxes and other measures.
Murray Aitken, vice president of IMS Health, the world's largest source of drug-price and sales data, and MIT professor Ernst Berndt will explain why their research shows that average drug prices for seniors have declined, not increased, by more than 20 percent.